Boston Scientific forecasts 2026 organic growth of 6.5% to 8% amid revised outlook for EP and WATCHMAN [Seeking Alpha]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Seeking Alpha
"First quarter represented a solid quarter for Boston Scientific with total company organic sales growth of 9.4% versus our guidance range of 8.5% to 10%." (Chairman, President & CEO Michael Mahoney) Fresh Stock Ideas, Every Day Quick Insights Management cited unanticipated headwinds and changing business patterns, with weakness in EP, WATCHMAN, and Urology segments contributing most to the guidance reduction. Key risks include competitive share erosion in EP, hospital capacity and reimbursement changes affecting WATCHMAN, and margin pressure from tariffs and discontinued POLARx system. The company is implementing stricter spend controls, focusing R&D, and making targeted commercial and marketing investments to address competitiveness in EP and WATCHMAN.
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire
- BSX Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- BSX Q3 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Boston Scientific (NYSE:BSX) Surprises With Q1 CY2026 Sales [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (BSX) had its price target lowered by Barclays PLC from $124.00 to $100.00. They now have an "overweight" rating on the stock.MarketBeat
BSX
Earnings
- 4/22/26 - In-Line
BSX
Sec Filings
- 4/22/26 - Form 8-K
- 4/2/26 - Form EFFECT
- 4/1/26 - Form 424B3
- BSX's page on the SEC website